LncRNA NBR2 is downregulated in NSCLC patients, and the overexpression of lncRNA NBR2 could inhibit the migration of lung cancer cells (SPC-A1 cells) and the Notch signaling pathways are also suppressed, and the EMT-related genes are also reduced (51). This evidence concerns the gene NBR2 and lung cancer.